ARCHIVES

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

This article is from The Cancer Letter archive.

Vol. 14 No. 13 | March 25, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Advanced Screening Provides More Accurate Diagnosis

February 23, 2007

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978